Drug Type Small molecule drug |
Synonyms D665-1412 |
Target |
Action inhibitors |
Mechanism RNF126 inhibitors(ring finger protein 126 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Cancer | Preclinical | China | 16 Jun 2026 |





